telmisartan has been researched along with Auricular Fibrillation in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (13.33) | 29.6817 |
| 2010's | 12 (80.00) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, J; Gan, Y; Jiang, H; Ma, H | 1 |
| Chen, H; Du, R; Han, H; Hu, L; Li, J; Li, W; Ma, L; Tian, L; Zhou, Q | 1 |
| Chen, S; Chen, W; Du, H; Fan, J; Lan, X; Ling, Z; Liu, Z; Su, L; Woo, K; Xiao, P; Xu, Y; Yin, Y; Zhou, B | 1 |
| Pan, G; Zhao, J; Zhou, X | 1 |
| Dong, H; Li, S; Li, Y; Ma, B; Pang, Z; Wang, L; Wang, T; Yang, J | 1 |
| Aoki, H; Hoshide, S; Kario, K; Matsumoto, Y; Mizuno, H; Noshiro, T; Okazaki, O; Uchiyama, K; Yoshida, T | 1 |
| Matsui, T; Nakamura, K; Yamagishi, SI | 1 |
| Derosa, G; Destro, M; Fogari, R; Lazzari, P; Mugellini, A; Preti, P; Zoppi, A | 1 |
| Cevik, C; Dindar, I; Kılıcarslan, F; Oduncu, V; Ozveren, O; Semiz, E; Sengul, C; Sunbul, A | 1 |
| Cagnoni, F; Cavalleri, C; Destro, M; Dognini, GP; Galimberti, V; Galli, E; Taietti, C | 1 |
| Kjeldsen, SE; Okin, PM | 1 |
| Binbrek, AS; Chazova, I; Dagenais, G; Dans, AL; Ferreira, R; Gao, P; Healey, J; Holwerda, N; Iacobellis, G; Karatzas, N; Keltai, M; Mancia, G; Sleight, P; Teo, K; Verdecchia, P; Yusuf, S | 1 |
| Derosa, G; Fogari, R; Maffioli, P; Mugellini, A; Perrone, T; Preti, P; Zoppi, A | 1 |
| Carbotta, S; Cittadini, A; Di Michele, S; Galzerano, D; Gaudio, C; Lama, D; Paolisso, G; Tedesco, MA; Tuccillo, B | 1 |
| Inoue, H; Takenaka, K; Yamagishi, S | 1 |
4 review(s) available for telmisartan and Auricular Fibrillation
| Article | Year |
|---|---|
Angiotensin Receptor Blocker and Calcium Channel Blocker Preventing Atrial Fibrillation Recurrence in Patients with Hypertension and Atrial Fibrillation: A Meta-analysis.
Topics: Amlodipine; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Atrial Fibrillation; Calcium Channel Blockers; Humans; Hypertension; Randomized Controlled Trials as Topic; Recurrence; Risk Factors; Telmisartan | 2021 |
Effect of telmisartan on atrial fibrillation recurrences in patients with hypertension: a systematic review and meta-analysis.
Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Atrial Fibrillation; Benzimidazoles; Benzoates; Chi-Square Distribution; Humans; Hypertension; Kaplan-Meier Estimate; Odds Ratio; Recurrence; Risk Assessment; Risk Factors; Telmisartan; Treatment Outcome | 2014 |
Possible molecular mechanisms by which angiotensin II type 1 receptor blockers (ARBs) prevent the development of atrial fibrillation in insulin resistant patients.
Topics: Angiotensin II Type 1 Receptor Blockers; Atrial Fibrillation; Benzimidazoles; Benzoates; Humans; Insulin Resistance; Telmisartan | 2008 |
Telmisartan: just an antihypertensive agent? A literature review.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Atrial Fibrillation; Benzimidazoles; Benzoates; Costs and Cost Analysis; Humans; Hypertension; Hypertrophy, Left Ventricular; Kidney Diseases; Renin-Angiotensin System; Telmisartan | 2011 |
7 trial(s) available for telmisartan and Auricular Fibrillation
| Article | Year |
|---|---|
Effects of telmisartan on paroxysmal atrial fibrillation in hypertensive patients.
Topics: Anti-Arrhythmia Agents; Antihypertensive Agents; Atrial Fibrillation; Biomarkers; Blood Pressure; C-Reactive Protein; China; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Recurrence; Telmisartan; Time Factors; Treatment Outcome | 2017 |
Effect of nifedipine versus telmisartan on prevention of atrial fibrillation recurrence in hypertensive patients.
Topics: Angiotensin II Type 1 Receptor Blockers; Atrial Fibrillation; Benzimidazoles; Benzoates; Blood Pressure; Calcium Channel Blockers; Dose-Response Relationship, Drug; Echocardiography; Electrocardiography; Female; Follow-Up Studies; Heart Atria; Heart Rate; Humans; Hypertension; Male; Middle Aged; Nifedipine; Prospective Studies; Secondary Prevention; Telmisartan; Treatment Outcome | 2013 |
Dose Timing of an Angiotensin II Receptor Blocker/Calcium Channel Blocker Combination in Hypertensive Patients With Paroxysmal Atrial Fibrillation.
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Atrial Fibrillation; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Circadian Rhythm; Drug Combinations; Female; Humans; Hypertension; Male; Natriuretic Peptide, Brain; Prospective Studies; Telmisartan; Treatment Outcome | 2016 |
Effect of telmisartan and ramipril on atrial fibrillation recurrence and severity in hypertensive patients with metabolic syndrome and recurrent symptomatic paroxysmal and persistent atrial fibrillation.
Topics: Aged; Atrial Fibrillation; Benzimidazoles; Benzoates; Double-Blind Method; Female; Follow-Up Studies; Humans; Hypertension; Male; Metabolic Syndrome; Prospective Studies; Ramipril; Secondary Prevention; Severity of Illness Index; Telmisartan; Treatment Outcome | 2012 |
Blood pressure and other determinants of new-onset atrial fibrillation in patients at high cardiovascular risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtoleran
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Anthropometry; Atrial Fibrillation; Benzimidazoles; Benzoates; Body Mass Index; Cardiovascular Diseases; Diabetes Complications; Double-Blind Method; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertrophy, Left Ventricular; Male; Middle Aged; Placebos; Ramipril; Risk; Risk Factors; Stroke; Telmisartan; Vitamin K | 2012 |
Effect of telmisartan on paroxysmal atrial fibrillation recurrence in hypertensive patients with normal or increased left atrial size.
Topics: Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atrial Fibrillation; Benzimidazoles; Benzoates; Calcium Channel Blockers; Double-Blind Method; Female; Heart Atria; Humans; Hypertension; Male; Recurrence; Risk Factors; Telmisartan | 2012 |
A multicentre, randomized study of telmisartan versus carvedilol for prevention of atrial fibrillation recurrence in hypertensive patients.
Topics: Adult; Aged; Antihypertensive Agents; Atrial Fibrillation; Benzimidazoles; Benzoates; Carbazoles; Carvedilol; Female; Heart Ventricles; Humans; Hypertension; Kaplan-Meier Estimate; Male; Middle Aged; Organ Size; Propanolamines; Recurrence; Telmisartan | 2012 |
4 other study(ies) available for telmisartan and Auricular Fibrillation
| Article | Year |
|---|---|
[Efficacy and safety of circumferential pulmonary vein isolation with the anterior pulmonary vein vestibule intensive ablation and upstream therapy for atrial fibrillation].
Topics: Atrial Appendage; Atrial Fibrillation; Benzimidazoles; Benzoates; Catheter Ablation; Combined Modality Therapy; Fluorobenzenes; Heart Atria; Humans; Postoperative Period; Pulmonary Veins; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Telmisartan | 2014 |
Telmisartan decreases atrial electromechanical delay in patients with newly diagnosed essential hypertension.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Atrial Fibrillation; Benzimidazoles; Benzoates; Echocardiography; Electrocardiography; Female; Heart Conduction System; Humans; Hypertension; Male; Middle Aged; Reproducibility of Results; Statistics, Nonparametric; Telmisartan; Treatment Outcome | 2012 |
Prediction and prevention of atrial fibrillation in patients with high blood pressure or history of hypertension.
Topics: Atrial Fibrillation; Benzimidazoles; Benzoates; Cardiovascular Diseases; Female; Humans; Male; Ramipril; Telmisartan | 2012 |
Role of insulin-sensitizing property of telmisartan, a commercially available angiotensin II type 1 receptor blocker in preventing the development of atrial fibrillation.
Topics: Angiotensin II Type 1 Receptor Blockers; Atrial Fibrillation; Benzimidazoles; Benzoates; Humans; Insulin Resistance; Telmisartan | 2006 |